Satsuma Pharmaceuticals, Inc.

STSA · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$16,429$15,835$36,326$22,755
Short-Term Investments$36,052$77,315$31,910$84,942
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,328$6,698$5,550$7,047
Total Curr. Assets$54,809$99,848$73,786$114,744
Property Plant & Equip (Net)$108$6,792$6,473$832
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$2,620$0$10,203
Tax Assets$0$0$0$0
Other NC Assets$22$572$774$497
Total NC Assets$130$9,984$7,247$11,532
Other Assets$0$0$0$0
Total Assets$54,939$109,832$81,033$126,276
Liabilities
Payables$1,911$1,469$3,381$4,282
Short-Term Debt$138$1,080$1,990$1,979
Tax Payable$0$0$0$0
Deferred Revenue$0$5,879$2,488$1,508
Other Curr. Liab.$6,066$64$187$202
Total Curr. Liab.$8,115$8,492$8,046$7,971
LT Debt$0$0$1,042$2,951
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$9$19
Total NC Liab.$2,049$0$1,051$2,970
Other Liabilities-$2,049$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$8,115$8,492$9,097$10,941
Equity
Pref Stock$54,939$109,832$81,033$126,276
Common Stock$3$3$2$2
Retained Earnings-$211,791-$141,736-$90,564-$43,001
AOCI-$30-$42$29$17
Other Equity-$54,912$133,283-$81,064-$126,295
Total Equity-$211,791$101,340-$90,564-$43,001
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$54,939$109,832-$81,467-$32,060
Net Debt-$16,291-$14,755-$33,294-$17,825
Satsuma Pharmaceuticals, Inc. (STSA) Financial Statements & Key Stats | AlphaPilot